There has been little notice of the Canadian government's recent action in a 15-year patent dispute with Harvard University, even though it may restoke the fires of controversy about the patenting of ...

The European Patent Office (EPO) upheld an amended form of a Harvard University patent on a mouse genetically modified to develop cancer earlier this week. The decision, which limits the patent to ...

After 17 years of wending its way through the maze of the Canadian court system the "Harvard mouse" has reached a blind alley. The Canadian Supreme Court ruled Thursday by a five–to–four decision that ...

The first patent for a genetically engineered animal-a mouse created by Harvard University scientists-predictably provoked new protests from environmentalists and bureaucrats. Although such reactions ...

When the Supreme Court of Canada ruled yesterday on the fate of the Harvard mouse, both the majority and the minority in the 5-4 decision made it clear what they weren't ruling on. "It is irrelevant," ...

The Supreme Court of Canada has rejected Harvard University’s application for a patent on its “oncomouse,” a genetically modified mouse used in cancer studies, ruling that it does not fit the criteria ...

Higher life-forms cannot be patented in Canada until Parliament specifically debates the ramifications and states that they can, the Supreme Court of Canada ruled Thursday. The decisive, 5-4 ruling ...

The human brain is a tangled highway of wires emanating from nearly 100 billion neurons, all of which communicate across trillions of junctions called synapses. "Depressingly complex," Harvard ...

The Supreme Court of Canada in December rejected Harvard University’s application for a patent on its “OncoMouse,” a genetically modified mouse used in cancer studies, ruling that the mouse does not ...